๐ฐ Statements This News
Page 2 - Statements This News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statements This. Real-time updates on events, politics, business and more.
March 30, 2022
Investegate announcements from Serinus Energy PLC, Director/PDMR Shareholding
February 4, 2022
First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England
January 10, 2022
500 1,000 1,500 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Significant Pent - Up Demand x Following the Great Recession, homeowner investment in... | January 10, 2022
October 29, 2021
Investegate announcements from Serinus Energy PLC, Director/PDMR Purchase of Shares
August 12, 2021
- Initiated Phase 2 VIBRANT study of vurolenatide for short bowel syndrome (SBS) in Q2; total stool output (TSO) is primary endpoint following FDA guidance -- Expect Phase 2 data from VIBRANT in Q4 2021
May 17, 2021
PQ Group Holdings," "the company," "we," "us" or "our" refer to PQ Group Holdings Inc. and its consolidated subsidiaries. Forward-looking Statements This periodic report on Form 10-Q ("Form 10-Q") includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements". The words "believe," "may," "will," "estimate," "continue," "anticipat...
May 13, 2021
- Company Closed a $31.5M equity offering in April 2021; provides cash runway into 2023 - Plan to initiate Phase 2 trial with NM-002 in SBS with total stool output as the primary endpoint in Q2 following
March 6, 2021
To get full access of the story, click here to subscribe to IANS News Service ยฉ 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 06-March-2021
March 2, 2021
Share this article DRESDEN, Germany, March 2, 2021 /PRNewswire/ -- ย GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to-treat cancers, today announced the publication of clinical data obtained from the ongoing Phase I study of their rapidly switchable UniCAR platform lead asset, UniCAR-T-CD123, in relapsed/refractory acute myeloid leukemia (rrAML), in the journal "Blood". The interim data of UniCAR-T-CD123 in rrAML, published online ahe...
January 12, 2021
News Category Global Banking & Finance Reviews General Cannabis Corp Strengthens Balance Sheet by Raising New Capital, Retiring Existing Debt and Extinguishing Put Obligation General Cannabis Corp Strengthens Balance Sheet by Raising New Capital, Retiring Existing Debt and Extinguishing Put Obligation DENVER, Jan. 04, 2021 โ General Cannabis Corp (OTCQB: CANN) today announced that it has raised over $2.9 million of senior convertible promissory notes (โNotesโ) and extinguished an existing...